Current guidelines recommend comprehensive molecular genotyping for newly diagnosed patients with metastatic non-squamous non-small cell lung cancer (NSCLC). A study presented at the American Society ...

EMR-based nudge interventions can influence molecular genotyping ordering behavior to promote comprehensive molecular testing and delivery of guideline-concordant care in the 1L treatment setting in ...

Obtaining molecular genotyping results before first-line treatment resulted in better outcomes for patients with non-small cell lung cancer, an expert explained. A recent study showed that undergoing ...

Per-protocol survival improved versus earlier cutoffs, with 35% alive beyond 30 months and 13% beyond 50 months after two ...

Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...

Please provide your email address to receive an email when new articles are posted on . Those who received ctDNA testing before tissue diagnosis had median time to treatment of 39 days vs. 62 days for ...

Testing blood samples from patients with advanced non–small cell lung cancer (NSCLC) for tumor mutations prior to their receiving a confirmed diagnosis via tissue biopsy can help shorten the time to ...

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ -- Lunit ...

Across three practice sites in a large health system, implementation of a provider team–focused EMR-based nudge intervention was feasible, and led to a higher number of patients with NSCLC undergoing ...